Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine …
K Robinson, A Gupta, V Dennis, K Arheart… - Circulation, 1996 - Am Heart Assoc
Background A high level of total plasma homocysteine is a risk factor for atherosclerosis,
which is an important cause of death in renal failure. We evaluated the role of this as a risk …
which is an important cause of death in renal failure. We evaluated the role of this as a risk …
Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study
Hyperhomocysteinemia occurs frequently in end-stage renal disease (ESRD), but its
prevalence in comparison with traditional cardiovascular disease (CVD) risk factors is …
prevalence in comparison with traditional cardiovascular disease (CVD) risk factors is …
The relationship between the concentration of plasma homocysteine and chronic kidney disease: a cross sectional study of a large cohort
E Cohen, I Margalit, T Shochat, E Goldberg… - Journal of nephrology, 2019 - Springer
Background High concentrations of homocysteine are considered a risk factor for
developing atherosclerosis and coronary artery disease. The aim of this study was to assess …
developing atherosclerosis and coronary artery disease. The aim of this study was to assess …
[PDF][PDF] ANALYZING THE IMPACT OF BIOLOGICAL PARAMETERS AND HOMOCYSTEINE CONTENT LEVELS ON PATIENTS UNDERGOING HAEMODIALYSIS
M Chandrakar, T Chandrakar - jcdronline.org
Background: Homocysteine levels are elevated in patients with renal disease, which causes
it to be excreted in urine. Raised homocysteine levels have been linked to renal illness; this …
it to be excreted in urine. Raised homocysteine levels have been linked to renal illness; this …
Clinical implication of hyperhomocysteinemia in hemodialysis patients: impact of nutritional status
SH KIM, YS KIM, YJ RYUE, KH RYUE… - Korean Journal of …, 2003 - pesquisa.bvsalud.org
BACKGROUND: Cardiovascular disease (CVD), especially ischemic heart disease (IHD)
and vascular access occlusion (VAO) is the most common morbidity in dialysis patients …
and vascular access occlusion (VAO) is the most common morbidity in dialysis patients …
Does N-Acetyl Cysteine Have a Dose-Dependent Effect on Plasma Homocysteine Concentration in Patients Undergoing Hemodialysis?
M Khosravi, M Shohrati, K Falaknazi - Nephro-Urology Monthly, 2009 - brieflands.com
: Introduction: High homocysteine (Hcy) levels in hemodialyzed patients are associated with
coronary disease. On the other hand, different effects were reported for impact of N-Acetyl …
coronary disease. On the other hand, different effects were reported for impact of N-Acetyl …
Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients
ZA Massy, B Chadefaux-Vekemans… - Nephrology Dialysis …, 1994 - academic.oup.com
Moderate hyperhomocysteinaemia has been shown to constitute an independent risk factor
for cardiovascular disease (CVD), a frequent cause of morbidity and mortality in renal …
for cardiovascular disease (CVD), a frequent cause of morbidity and mortality in renal …
The Influence of the Cooperation of Hyperhomocysteinemia and Arterial Hypertension. A Risk Factor on the Acceleration of the Progress of Chronic Renal Diseases
A Zylbeari, E Masha, Z Bexheti… - Albanian Journal of …, 2024 - journal.astes.org.al
Introduction: Chronic kidney disease (CKD) is a heterogeneous group of disorders that
manifest differently with a multifactorial etiology. In addition to known factors such as …
manifest differently with a multifactorial etiology. In addition to known factors such as …
[HTML][HTML] Prevalence of elevated levels of homocysteine (hyperhomocysteinemia) in patients with chronic kidney disease undergoing hemodialysis
RT Pinzon, BM Wijaya, EA Pramudita… - Journal of Clinical …, 2019 - cyberleninka.ru
Background: Chronic kidney disease is a disease with kidney damage of more than 3
months. Chronic kidney disease has five stages, in which in the fifth stage the patient …
months. Chronic kidney disease has five stages, in which in the fifth stage the patient …
Homocysteine and cardiovascular risk in dialysis patients
C Rigatto, PS Parfrey - Peritoneal Dialysis International, 2000 - journals.sagepub.com
RIGATTO and PARFREY MARCH 2000–VOL. 20, NO. 2 PDI findings. The use of prevalent
as opposed to incident patients introduces the possibility of survivorship bias. These …
as opposed to incident patients introduces the possibility of survivorship bias. These …